We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Knotless Tissue Control Device Transforms Tissue Repair

By HospiMedica International staff writers
Posted on 30 Oct 2012
An innovative barbed suture offers significantly more points of fixation than traditional sutures, giving surgeons more consistent control over every pass.

The Stratafix Knotless Tissue Control Device is bidirectional barbed suture with barbs spaced at one mm steps in a spiral pattern along the suture; at midpoint, the barbs change direction. More...
The anchors that run along the length of the device prevent it from loosening, making it easier for surgeons to control tension and maintain approximation, without assistance, thus combining the strength and security of interrupted closure with the efficiency of continuous closure.

The anchors also eliminate the need to tie knots, removing the possibility of knot-related complications and allowing surgeons to operate more efficiently. Another advantage is that surgeons can close wounds substantially faster than when using an interrupted technique, meaning that patients also require less time under anesthesia. The Stratafix Knotless Tissue Control Device is a product of Ethicon (Somerville, NJ, USA).

“The Stratfix portfolio paves the way for the development of entirely new surgical approaches that will transform the surgeon’s tissue repair and restoration experience, representing the future of wound closure,” said Tim Schmid, president of Ethicon U.S. “This product launch demonstrates our commitment to making investments in technology that will advance surgery. By utilizing Ethicon’s global reach and partnerships, we can bring the benefits of barbed suturing technology to more patients than previously possible.”

Related Links:

Ethicon



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.